James B. Doub

657 total citations
46 papers, 429 citations indexed

About

James B. Doub is a scholar working on Surgery, Ecology and Infectious Diseases. According to data from OpenAlex, James B. Doub has authored 46 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 16 papers in Ecology and 14 papers in Infectious Diseases. Recurrent topics in James B. Doub's work include Orthopedic Infections and Treatments (27 papers), Bacteriophages and microbial interactions (16 papers) and Orthopaedic implants and arthroplasty (7 papers). James B. Doub is often cited by papers focused on Orthopedic Infections and Treatments (27 papers), Bacteriophages and microbial interactions (16 papers) and Orthopaedic implants and arthroplasty (7 papers). James B. Doub collaborates with scholars based in United States, Nigeria and China. James B. Doub's co-authors include Vincent Y. Ng, Benjamin K. Chan, Aaron J. Johnson, Joseph Fackler, Emily L. Heil, Bri’Anna Horne, Eleanor Wilson, Francisco Malagón, Matthew Henry and Biswajit Biswas and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Orthopaedic Research® and The Journal of Arthroplasty.

In The Last Decade

James B. Doub

40 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James B. Doub United States 13 277 149 124 115 112 46 429
Olivier Grossi France 9 209 0.8× 61 0.4× 114 0.9× 89 0.8× 74 0.7× 14 401
Sarah Djebara Belgium 9 424 1.5× 62 0.4× 194 1.6× 148 1.3× 100 0.9× 20 533
Rebecca L. Pavlicek United States 8 124 0.4× 32 0.2× 95 0.8× 100 0.9× 58 0.5× 11 364
Aleksandre Ujmajuridze Switzerland 5 384 1.4× 26 0.2× 171 1.4× 143 1.2× 80 0.7× 7 532
Krzysztof Szufnarowski Poland 6 528 1.9× 26 0.2× 226 1.8× 144 1.3× 110 1.0× 9 586
Rodrigo Monteiro Brazil 8 307 1.1× 28 0.2× 120 1.0× 165 1.4× 53 0.5× 22 406
Rory Eutsey United States 13 50 0.2× 42 0.3× 264 2.1× 183 1.6× 45 0.4× 25 541
Katherine E. Bowden United States 11 42 0.2× 34 0.2× 415 3.3× 178 1.5× 78 0.7× 20 627
Brandi Herter United States 6 79 0.3× 39 0.3× 31 0.3× 61 0.5× 86 0.8× 8 272
Sophio Rigvava Georgia 5 319 1.2× 10 0.1× 155 1.3× 127 1.1× 46 0.4× 9 394

Countries citing papers authored by James B. Doub

Since Specialization
Citations

This map shows the geographic impact of James B. Doub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B. Doub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B. Doub more than expected).

Fields of papers citing papers by James B. Doub

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James B. Doub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B. Doub. The network helps show where James B. Doub may publish in the future.

Co-authorship network of co-authors of James B. Doub

This figure shows the co-authorship network connecting the top 25 collaborators of James B. Doub. A scholar is included among the top collaborators of James B. Doub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James B. Doub. James B. Doub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Putnam, Nicole E., et al.. (2025). Broad-range polymerase chain reaction and sequencing for the diagnosis of infectious diseases. Microbiology Spectrum. 13(4). e0250524–e0250524.
2.
Doub, James B., et al.. (2025). Feasibility and Potential Clinical Ramifications of Using Bacteriophage Therapy for S. aureus Necrotizing Fasciitis. Journal of Clinical Medicine. 14(16). 5609–5609.
3.
Doub, James B., et al.. (2024). Risk Factors for Infection Recurrence After Surgical Resection of Advanced Stage Osteonecrosis of the Mandible. Journal of Oral and Maxillofacial Surgery. 82(3). 332–340. 10 indexed citations
4.
Doub, James B., et al.. (2024). The Location of Biofilms on Chronic Prosthetic Joint Infections and the Ramifications for Clinical Practice. Arthroplasty Today. 25. 101314–101314. 3 indexed citations
5.
Doub, James B., et al.. (2023). The stability of Staphylococcal bacteriophages with commonly used prosthetic joint infection lavage solutions. Journal of Orthopaedic Research®. 42(3). 555–559. 1 indexed citations
6.
Doub, James B., et al.. (2023). Bacterial Burden, Not Local Immune Response, Differs Between Acute and Chronic Peri-Prosthetic Joint Infections. Surgical Infections. 24(6). 549–553. 1 indexed citations
7.
Doub, James B., Emily L. Heil, & Theodore T. Manson. (2023). Adjuvant intra-articular vancomycin for recalcitrant Staphylococcal prosthetic joint infections of the knee. European Journal of Orthopaedic Surgery & Traumatology. 34(2). 1031–1036. 1 indexed citations
8.
Doub, James B., et al.. (2023). A rare case of Sphingomonas paucimobilis ventriculitis. GERMS. 13(3). 254–258.
9.
Doub, James B.. (2023). A pilot study for evaluating the feasibility of using alpha-defensin to support the diagnosis of ventriculitis. International Journal of Infectious Diseases. 132. 80–83.
10.
Doub, James B., Talal Alkayali, Anthony Amoroso, Sumon Nandi, & Rohit Talwani. (2023). Effective use of a two-dose regimen of dalbavancin to treat prosthetic joint infections and spinal hardware infections. European Journal of Orthopaedic Surgery & Traumatology. 33(8). 3655–3659. 4 indexed citations
11.
Doub, James B.. (2023). Is Corynebacterium striatum an emerging prosthetic joint infection pathogen and how should it be treated?. GERMS. 13(2). 151–157. 2 indexed citations
12.
Doub, James B., et al.. (2023). Feasibility of Using Bacteriophage Therapy to Reduce Morbidity and Mortality Associated with Spinal Epidural Abscesses. Infection and Chemotherapy. 55(2). 257–257. 1 indexed citations
13.
Doub, James B., et al.. (2023). Do All Prosthetic Joint Infection Clinical Isolates Form Aggregates in Synovial Fluid That Are Resistant to Antibiotic Agents?. Surgical Infections. 25(1). 71–76. 1 indexed citations
14.
Doub, James B., et al.. (2022). Impact of Bacterial Phenotypic Variation with Bacteriophage therapy: A Pilot Study with Prosthetic Joint Infection Isolates. International Journal of Infectious Diseases. 119. 44–46. 15 indexed citations
15.
Doub, James B., et al.. (2022). Tuberculosis the great masquerader. IDCases. 29. e01541–e01541. 1 indexed citations
16.
Doub, James B.. (2022). Use of α-Defensins to Help Diagnose Nosocomial Ventriculitis. Neurocritical Care. 38(2). 225–228. 2 indexed citations
17.
Joshi, Manjari, et al.. (2021). Evaluation of Intra-Operative Topical Vancomycin and the Incidence of Acute Kidney Injury. Surgical Infections. 22(8). 810–817. 3 indexed citations
18.
Doub, James B.. (2021). A rare case of Campylobacter rectus pyogenic extensor tenosynovitis. GERMS. 11(4). 604–607. 1 indexed citations
19.
Doub, James B.. (2021). Risk of Bacteriophage Therapeutics to Transfer Genetic Material and Contain Contaminants Beyond Endotoxins with Clinically Relevant Mitigation Strategies. Infection and Drug Resistance. Volume 14. 5629–5637. 21 indexed citations
20.
Doub, James B., Vincent Y. Ng, Aaron J. Johnson, et al.. (2020). Salvage Bacteriophage Therapy for a Chronic MRSA Prosthetic Joint Infection. Antibiotics. 9(5). 241–241. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivier Grossi Breakdown of academic impact, for papers by Sarah Djebara Breakdown of academic impact, for papers by Rebecca L. Pavlicek Breakdown of academic impact, for papers by Aleksandre Ujmajuridze Breakdown of academic impact, for papers by Krzysztof Szufnarowski Breakdown of academic impact, for papers by Rodrigo Monteiro Breakdown of academic impact, for papers by Rory Eutsey Breakdown of academic impact, for papers by Katherine E. Bowden Breakdown of academic impact, for papers by Brandi Herter Breakdown of academic impact, for papers by Sophio Rigvava
Rankless by CCL
2026